title: What liver transplant outcomes can be expected in the uninsured who become insured via the Affordable Care Act?
abstract: Our study objective is to measure the survival impact of insurance status following liver transplantation in a cohort of uninsured "charity care" patients. These patients are analogous to the population who will gain insurance via the Affordable Care Act. We hypothesize there will be reduced survival in charity care compared to other insurance strata. We conducted a retrospective study of 898 liver transplants from 2000 to 2010. Insurance cohorts were classified as private (n = 640), public (n = 233) and charity care (n = 23). The 1, 3 and 5-year survival was 92%, 88% and 83% in private insurance, 89%, 80% and 73% in public insurance and 83%, 72% and 51% in charity care. Compared to private insurance, multivariable regression analyses demonstrated charity care (HR 3.11, CI 1.41-6.86) and public insurance (HR 1.58, CI 1.06-2.34) had a higher 5-year mortality hazard ratio. In contrast, other measures of socioeconomic status were not significantly associated with increased mortality. The charity care cohort demonstrated the highest incidence of acute rejection and missed clinic appointments. These data suggest factors other than demographic and socioeconomic may be associated with increased mortality. Further investigations are necessary to determine causative predictors of increased mortality in liver transplant patients without private insurance.
authors: School of Medicine, University of Alabama, Birmingham, AL, USA.
authors: L N
authors: LN
authors: Glueckert
authors: D
authors: D
authors: Redden
authors: M A
authors: MA
authors: Thompson
authors: A
authors: A
authors: Haque
authors: S H
authors: SH
authors: Gray
authors: J
authors: J
authors: Locke
authors: D E
authors: DE
authors: Eckhoff
authors: M
authors: M
authors: Fouad
authors: D A
authors: DA
authors: DuBay
mesh_terms: D000328:Adult; D005260:Female; D006297:Health Services Accessibility / Q000191:economics*; D006801:Humans; D019458:Insurance Coverage / Q000191:economics*; D007348:Insurance, Health / Q000191:economics*; D016031:Liver Transplantation / Q000191:economics* / Q000401:mortality; D008297:Male; D017057:Medically Uninsured / Q000706:statistics & numerical data*; D008875:Middle Aged; D058991:Patient Protection and Affordable Care Act; D011379:Prognosis; D012189:Retrospective Studies; D015996:Survival Rate / Q000639:trends; D014481:United States / Q000453:epidemiology
references: J Clin Oncol. 2009 Aug 1;27(22):3627-33
references: 19470927
references: JAMA. 2008 Jan 9;299(2):202-7
references: 18182602
references: Am J Transplant. 2009 Sep;9(9):2092-101
references: 19645706
references: Clin J Am Soc Nephrol. 2006 Mar;1(2):313-22
references: 17699222
references: Cancer. 2004 Nov 15;101(10):2187-94
references: 15382089
references: J Heart Lung Transplant. 2012 Jan;31(1):52-60
references: 21959122
references: CA Cancer J Clin. 2008 Jan-Feb;58(1):9-31
references: 18096863
references: Am J Transplant. 2006 Apr;6(4):783-90
references: 16539636
references: J Natl Cancer Inst. 2002 Apr 3;94(7):490-6
references: 11929949
references: Transplantation. 2008 Jan 27;85(2):166-70
references: 18212619
references: Dig Dis Sci. 2009 Aug;54(8):1794-7
references: 19051029
references: Transplant Proc. 2011 Jan-Feb;43(1):155-7
references: 21335175
references: Liver Transpl. 2004 Feb;10(2):235-43
references: 14762861
references: J Clin Psychol. 1999 Oct;55(10):1287-97
references: 11045777
references: Transplant Proc. 2011 Dec;43(10):3780-2
references: 22172846
references: J Heart Lung Transplant. 2011 Jan;30(1):45-53
references: 20869264
references: Ann Surg. 2010 Oct;252(4):652-61
references: 20881772
references: Pediatr Transplant. 2007 Mar;11(2):127-31
references: 17300489